BP12858
|
Lup-20(29)-en-28-oic acid
|
|
|
|
Lup-20(29)-en-28-oic acid exhibits anticancer activities in various cancer types, it Inhibits autophagic flux and synergistically enhances the anticancer activity of chemotherapeutic agents against HeLa cells.Pulsatilla saponin D has strong haemolytic activity.
|
BP12859
|
Degrasyn
|
|
|
|
Degrasyn (WP1130), a specific deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor, also inhibits Bcr/Abl, which is a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).
|
BP12860
|
Indomethacin farnesil
|
|
|
|
Infree is a prodrug of indomethacin. It acts as a nonsteroidal anti-inflammatory drug (NSAID) and disease-modifying anti-rheumatic drug (DMARD).
|
BP12861
|
EACC
|
|
|
|
EACC selectively inhibits the translocation of autophagosome-specific SNARE Stx17 thereby blocking autophagosome-lysosome fusion. EACC is a reversible autophagy inhibitor.
|
BP12862
|
Briciclib
|
|
|
|
Briciclib is a small molecule that suppresses cyclin D1 accumulation in Y cells.
|
BP12863
|
Belinostat
|
|
|
|
Belinostat is an inhibitor of hydroxamic acid-type histone deacetylase (HDAC, IC50 of 27 nM in HeLa cell extracts),and with antineoplastic activity.
|
BP12864
|
SN-38
|
|
|
|
SN-38 is an active metabolite of CPT-11.
|
BP12865
|
Dorsomorphin
|
|
|
|
Dorsomorphin is an effective and specific inhibitor of AMPK (AMP-activated protein kinase), which is induced by AICAR and metformin.
|
BP12866
|
Idelalisib
|
|
|
|
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
|
BP12867
|
Ivacaftor
|
|
|
|
Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.
|
BP12868
|
IKK 16
|
|
|
|
IKK-16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
|
BP12869
|
S29434
|
|
|
|
S29434 (NMDPEF) is a potent, competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
|
BP12870
|
LY2183240
|
|
|
|
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
|
BP12871
|
Hoechst 33342 trihydrochloride
|
|
|
|
Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.
|
BP12872
|
Vismodegib
|
|
|
|
Vismodegib is a hedgehog pathway inhibitor (IC50: 3 nM). It also inhibits P-gp (IC50: 3.0 μM), ABCG2 (IC50: 1.4 μM).
|
BP12873
|
Xylitol
|
|
|
|
Xylitol is a five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.
|
BP12874
|
AMD-070 hydrochloride
|
|
|
|
AMD-070 hydrochloride is a CXCR4 antagonist, is useful for Anti HIV.
|
BP12875
|
Notoginsenoside Fc
|
|
|
|
Notoginsenoside Fc has perfect anti-platelet aggregatory effect.
|
BP12876
|
N-Benzyllinolenamide
|
|
|
|
N-Benzyllinolenamide is a natural product. It is an inhibitor of fatty acid amide hydrolase (FAAH, IC50 of 41.8 μM).
|
BP12877
|
CCT128930
|
|
|
|
CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM, 28-fold greater selectivity for Akt2 than the closely related PKA kinase.
|